19-08-2021 дата публикации
Номер: US20210254174A1
Принадлежит:
GECKO BIOLAB
The present disclosure relates to the use of genes whose expression or protein changes specifically to hepatocellular carcinoma as biomarkers for the detection and diagnosis of hepatocellular carcinoma, in which the biomarkers of the present disclosure, HMMR, NXPH4, PITX1, THBS4, and UBE2T, since they change their expression specifically to hepatocellular carcinoma, may be used as hepatocellular carcinoma-specific markers, and furthermore, these biomarkers may be used independently or in combination with AFP, or may be independently combined to make a more specific and accurate diagnosis of hepatocellular carcinoma. 1. A biomarker for diagnosis of liver cancer , the biomarker comprising at least one gene selected from a group consisting of AFP (α-fetoprotein) , HMMR (hyaluronan-mediated motility receptor) , NXPH4 (neurexophilin 4) , PITX1 (paired-like homeodomain 1) , THBS4 (thrombospondin 4) and UBE2T (ubiquitin-conjugating enzyme E2T) or a protein expressed from the at least one gene.2. The biomarker of claim 1 , wherein the liver cancer is hepatocellular carcinoma (HCC).3. The biomarker of claim 2 , wherein the hepatocellular carcinoma includes early hepatocellular carcinoma or advanced hepatocellular carcinoma.4. A composition for diagnosis of liver cancer claim 2 , the composition comprising an agent for measuring an expression level of one or more biomarker genes selected from a group consisting of AFP claim 2 , HMMR claim 2 , NXPH4 claim 2 , PITX1 claim 2 , THBS4 and UBE2T at an mRNA or protein level.5. The composition of claim 4 , wherein the composition includes an agent for measuring an expression level of one or more biomarker gene sets selected from a group consisting of AFP and HMMR claim 4 , AFP and NXPH4 claim 4 , AFP and PITX1 claim 4 , AFP and THBS4 claim 4 , AFP and UBE2T claim 4 , HMMR and NXPH4 claim 4 , HMMR and PITX1 claim 4 , HMMR and THBS4 claim 4 , HMMR and UBE2T claim 4 , NXPH4 and PITX1 claim 4 , NXPH4 and THBS4 claim 4 , NXPH4 and UBE2T ...
Подробнее